 Disease Progression
"Disease Progression" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
| Descriptor ID |
D018450
|
| MeSH Number(s) |
C23.550.291.656
|
| Concept/Terms |
Disease Progression- Disease Progression
- Disease Progressions
- Progression, Disease
- Progressions, Disease
|
Below are MeSH descriptors whose meaning is more general than "Disease Progression".
Below are MeSH descriptors whose meaning is more specific than "Disease Progression".
This graph shows the total number of publications written about "Disease Progression" by people in this website by year, and whether "Disease Progression" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 2 | 2 | | 1995 | 0 | 5 | 5 | | 1996 | 0 | 11 | 11 | | 1997 | 0 | 7 | 7 | | 1998 | 0 | 12 | 12 | | 1999 | 0 | 7 | 7 | | 2000 | 0 | 20 | 20 | | 2001 | 0 | 17 | 17 | | 2002 | 0 | 24 | 24 | | 2003 | 0 | 25 | 25 | | 2004 | 0 | 38 | 38 | | 2005 | 0 | 37 | 37 | | 2006 | 0 | 49 | 49 | | 2007 | 1 | 39 | 40 | | 2008 | 0 | 43 | 43 | | 2009 | 3 | 53 | 56 | | 2010 | 2 | 50 | 52 | | 2011 | 2 | 49 | 51 | | 2012 | 2 | 55 | 57 | | 2013 | 2 | 51 | 53 | | 2014 | 3 | 55 | 58 | | 2015 | 4 | 56 | 60 | | 2016 | 3 | 50 | 53 | | 2017 | 6 | 54 | 60 | | 2018 | 9 | 64 | 73 | | 2019 | 4 | 52 | 56 | | 2020 | 3 | 52 | 55 | | 2021 | 5 | 32 | 37 | | 2022 | 0 | 17 | 17 |
To return to the timeline, click here.
Below are the most recent publications written about "Disease Progression" by people in Profiles.
-
Baugh A, Buhr RG, Quibrera P, Barjaktarevic I, Barr RG, Bowler R, Han MK, Kaufman JD, Koch AL, Krishnan J, Labaki W, Martinez FJ, Mkorombindo T, Namen A, Ortega V, Paine R, Peters SP, Schotland H, Sundar K, Zeidler MR, Hansel NN, Woodruff PG, Thakur N. Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity. Sleep. 2022 08 11; 45(8).
-
Kindler HL, Hammel P, Reni M, Van Cutsem E, Macarulla T, Hall MJ, Park JO, Hochhauser D, Arnold D, Oh DY, Reinacher-Schick A, Tortora G, Algül H, O'Reilly EM, Bordia S, McGuinness D, Cui K, Locker GY, Golan T. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. J Clin Oncol. 2022 12 01; 40(34):3929-3939.
-
Oldham JM, Lee CT, Wu Z, Bowman WS, Pugashetti JV, Dao N, Tonkin J, Seede H, Echt G, Adegunsoye A, Chua F, Maher TM, Garcia CK, Strek ME, Newton CA, Molyneaux PL. Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6).
-
Bakris GL, Weir MR. Initial Drops in Glomerular Filtration Rate with Certain Drug Classes Retard Kidney Disease Progression. Am J Nephrol. 2022; 53(7):513-515.
-
Tuttle KR, Agarwal R, Alpers CE, Bakris GL, Brosius FC, Kolkhof P, Uribarri J. Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney Int. 2022 08; 102(2):248-260.
-
Dallal-York J, Segalewitz T, Croft K, Colsky J, DiBiase L, Anderson A, Vasilopoulos T, Pelaez A, Shahmohammadi A, Pipkin M, Machuca TN, Plowman EK. Incidence, risk factors, and sequelae of dysphagia mediated aspiration following lung transplantation. J Heart Lung Transplant. 2022 08; 41(8):1095-1103.
-
Brankovic M, Jovanovic I, Dukic M, Radonjic T, Opric S, Klašnja S, Zdravkovic M. Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. Int J Mol Sci. 2022 May 05; 23(9).
-
Khan MS, Bakris GL, Shahid I, Weir MR, Butler J. Potential Role and Limitations of Estimated Glomerular Filtration Rate Slope Assessment in Cardiovascular Trials: A Review. JAMA Cardiol. 2022 05 01; 7(5):549-555.
-
Lee J, White E, Freiheit E, Scholand MB, Strek ME, Podolanczuk AJ, Patel NM. Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry. Chest. 2022 09; 162(3):603-613.
-
Taylor GS, Shaw AC, Smith K, Wason J, McDonald TJ, Oram RA, Stevenson E, Shaw JAM, West DJ. Capturing the real-world benefit of residual ß-cell function during clinically important time-periods in established Type 1 diabetes. Diabet Med. 2022 05; 39(5):e14814.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|